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Translocation of the Na+/H+ exchanger 1 (NHE1) in cardiomyocyte 
responses to insulin and energy-status signalling 
Scott P. LAWRENCE1, Geoffrey D. HOLMAN2 and Franc¸oise KOUMANOV 
Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath BA2 7AY, U.K. 
The Na+/H+  exchanger NHE1 is a highly regulated membrane 
protein that is required for pH homoeostasis in cardiomyocytes. 
The activation of NHE1 leads to proton extrusion, which is 
essential for counteracting cellular acidity that occurs following 
increased metabolic activity or ischaemia. The activation of 
NHE1 intrinsic catalytic activity has been well characterized 
and established experimentally. However, we have examined 
in the present study whether a net translocation of NHE1 to 
the sarcolemma of cardiomyocytes may also be involved in the 
activation process. We have determined the distribution of NHE1 
by means of immunoﬂuorescence microscopy and cell-surface 
biotinylation. We have discovered changes in the distribution 
of NHE1 that occur when cardiomyocytes are stimulated with 
insulin that are PI3K (phosphoinositide 3-kinase)-dependent. 
Translocation of NHE1 also occurs when cardiomyocytes 
are challenged by hypoxia, or inhibition of mitochondrial 
oxidative metabolism or electrically induced contraction, but 
these responses occur through a PI3K-independent process. 
As the proposed additional level of control of NHE1 through 
translocation was unexpected, we have compared this process 
with the well-established translocation of the glucose transporter 
GLUT4. In immunoﬂuorescence microscopy comparisons, the 
translocation of NHE1 and GLUT4 to the sarcolemma that occur 
in response to insulin appear to be very similar. However, in 
basal unstimulated cells the two proteins are mainly located, 
with the exception of some co-localization in the perinuclear 
region, in distinct subcellular compartments. We propose that the 
mechanisms of translocation ofNHE1 andGLUT4 are linked such 
that they provide spatially and temporally co-ordinated responses 
to cardiac challenges that necessitate re-adjustments in glucose 
transport, glucose metabolism and cell pH. 
Key words: cardiomyocyte, cell energy status, glucose transporter 
isoform 4 (GLUT4) translocation, insulin, Na+/H+  exchanger 1 
(NHE1) translocation. 
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INTRODUCTION 
The mammalian NHE (Na+/H+  exchanger) family of proteins 
plays an important role in maintenance of pHi (intracellular pH) 
[1]. Nine isoforms have been described in mammalian genomes. 
NHEs 1 and 6 –9 have a ubiquitous expression and NHEs 2–5 
have selective tissue expression [2]. NHE2 and NHE3 are 
predominantly expressed in apical membranes of kidney and 
intestinal epithelial cells [3,4], whereas NHE4 is highly expressed 
in the stomach [5]. NHE5 is almost exclusively expressed in 
the brain, although low levels of expression are also reported 
in spleen, testes and skeletal muscles [6,7]. In the mammalian 
myocardium, the only plasma membrane isoform is NHE1, and 
this exchanger plays a crucial role in the maintenance of pHi 
in healthy cells and impairment in its function is associated 
with disease states [8]. NHE1 activity is primarily regulated by 
decreases in pHi and maximal catalytic activity of the transporter 
is achieved at pHi 6.5 or less [9,10]. NHE1 has been directly 
implicated in, and has been found to be associated with, damage 
caused by ischaemia/reperfusion injuries and by hypertrophy [11]. 
For these reasons, NHE1 is a major pharmacological target for 
development of cardioprotective drugs [12]. 
NHE1 has been described as a relatively immobile actin-
anchored plasma membrane protein [13,14]. In many tissues, 
NHE1 activity is stimulated by growth and hormonal factors, 
including serum, EGF (epidermal growth factor) and insulin, 
which leads to proton extrusion and a transient cell alkalinization 
[15–18]. Hormonal stimulations have been linked to direct 
phosphorylation of NHE1 by protein kinases, including 
ERK (extracellular-signal-regulated kinase) 1/2, p160ROCK 
(p160 Rho-associated kinase), p38 MAPK (mitogen-activated 
protein kinase), p90 ribosomal S6K (S6 kinase), CaMKII 
(Ca2+/calmodulin-dependent protein kinase II) and Akt, and to 
dephosphorylation dependent upon the protein phosphatases PP1, 
PP2A and SHP-2 (Src homology 2 domain-containing protein 
tyrosine phosphatase 1/2). The changes in phosphorylation 
are thought to modulate the catalytic activity of the 
exchanger, possibly through altered interaction of the C-terminal 
cytoplasmic tail of NHE1 with the actin cytoskeleton (reviewed 
in [1,8]). 
Previous studies on P-type transporters including the Na+/K+ 
ATPase [19,20] have revealed that, in addition to regulation 
via changes in intrinsic catalytic activity, changes in activity 
are also associated with translocation of these proteins from 
reservoir compartments within the cell to sites where the ion 
channel activity becomes functionally important. Phosphorylation 
of aquaporin 2 in the kidney appears to be critical both for 
initiating translocation and determining the cellular compartment 
to which translocation occurs [21]. It therefore seems pertinent to 
determine whether, in addition to the well-established control via 
phosphorylation-dependent changes in catalytic activity, NHE1 
activity could also be regulated by translocation. 
Abbreviations used: AMPK, AMP-activated protein kinase; CaMKII, Ca2+/calmodulin-dependent protein kinase II; ERK, extracellular-signal-regulated 
kinase; GLUT4, glucose transporter isoform 4; GST, glutathione transferase; HA, haemagglutinin; KRH, Krebs-Ringer-Hepes; LcH, Lens culinaris agglutinin; 
NHE, Na+/H+ exchanger; pHi, intracellular pH; PI3K, phosphoinositide 3-kinase; TBS, Tris-buffered saline. 
1 Present address: Institute for Structural and Molecular Biology, Division of Biosciences, University College London, Gower Street, London WC1E 6BT, 
U.K. 
2 To whom correspondence should be addressed (email g.d.holman@bath.ac.uk). 
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The translocation process and its underlying mechanisms have 
been most extensively studied for GLUT4 (glucose transporter 
isoform 4), which is regulated by insulin action, and also 
in response to changes in the cell energy status. Cellular 
responses to insulin, but not to changes in cell energy status, 
are mediated through PI3K (phosphoinositide 3-kinase). Cardiac 
cell stimulation following hypoxia and inhibition of oxidative 
mitochondrial metabolism culminate in GLUT4 translocation 
that is initiated by, or dependent upon, signalling-induced 
changes in AMPK (AMP-activated protein kinase). The GLUT4 
translocation mediated through AMPK is functionally important 
as the resultant increase in cellular glucose transport can lead to 
the readjustment and replenishment of cell glucose metabolism 
and ATP levels. Our previous study has shown that insulin action 
on GLUT4 translocation and NHE1 activity are intricately linked, 
demonstrated by the ﬁnding that NHE1 activity is required for 
optimal GLUT4 translocation [17]. Cariporide, an NHE inhibitor 
[22], prevented the insulin-induced cytosol alkalinization and the 
associated insulin-stimulated GLUT4 translocation and glucose 
uptake [17]. 
To explore further the link between NHE1 activity and 
GLUT4 translocation, we have examined in the present study the 
hypothesis that the NHE1 transporter may also be translocated 
in response to the same treatments that stimulate GLUT4 
translocation. Based on data from use of the complementary 
techniques of confocal microscopy and cell-surface biotiny­
lation, the present study has revealed that there is a signiﬁcant 
translocation of NHE1 in cardiomyocytes in responses to insulin, 
hypoxia and electrically induced contraction that is similar to the 
established translocation process of GLUT4. 
EXPERIMENTAL 
Reagents 
All chemicals, unless otherwise stated, were sourced from 
Sigma–Aldrich. Type II collagenase was from Worthington 
Biochemicals. Fatty-acid-free BSA was obtained from Roche 
Molecular Biochemicals. Insulin was from Novo Nordisk. 
Generation and puriﬁcation of rabbit anti-rat NHE1 antibody 
For the purpose of generating a speciﬁc antibody recognizing 
rat cardiomyocyte NHE1 in immunocytochemistry experiments, 
a 503 bp cDNA fragment corresponding to the last 157 
amino acids from rat NHE1 (CT-NHE1) was ampliﬁed from 
a Marathon (Clontech) rat heart cDNA library prepared as 
described previously [23]. The primers used for the 
ampliﬁcation contained restriction sites for BglII and EcoRI 
(5′-GtggccAGATCTtacGAGGAAGCCTGGAACCAG-3′ and 5′-
CtagGAATTCtCTACTGCCCTTTGGGGATG-3′) allowing dir­
ect subcloning into pGEX-2T vector (GE Healthcare). The GST 
(glutathione transferase)-fusion protein was expressed in the 
BL21 strain of Escherichia coli. The GST–NHE1 fusion protein 
was puriﬁed by afﬁnity chromatography using glutathione– 
Sepharose 4B columns (GE Healthcare) and was then dialysed 
against PBS (12.5 mmol/l Na2HPO4 and 154 mmol/l NaCl, 
pH 7.2). Puriﬁed protein was used as an antigen for the preparation 
of a polyclonal rabbit serum. Antiserum was generated in New 
Zealand White rabbits at Harlan-Sera (UK) using a standard 
immunization protocol. 
The speciﬁc IgGs were puriﬁed from the immune serum 
using an afﬁnity column with immobilized C-terminal NHE1 
protein fragment (as above, but lacking the GST fusion, which 
was removed by thrombin treatment). The speciﬁcity of the 
© The Authors Journal compilation c© 2010 Biochemical Society 
antibody was tested using whole-cell cardiomyocyte lysates. 
The antibody speciﬁcally recognized bands at 110 kDa and 
85 kDa corresponding to the two glycosylated forms of NHE1 
described previously in cardiomyocytes [24,25]. 
Cardiomyocyte isolation and stimulation 
The study was approved by the University of Bath Institutional 
Animal Care and Use Committee. Cardiomyocytes from adult 
male Wistar rats (260–280 g) were prepared by collagenase 
digestion by use of a previously described method [17], but 
with the inclusion of 2 mmol/l inosine in the medium. Cell 
suspensions were adjusted to ≈10 % cytocrit in KRH (Krebs-
Ringer-Hepes) buffer (128 mmol/l NaCl, 6 mmol/l KCl, 1 mmol/l 
Na2HPO4, 0.2 mmol/l NaHPO4, 1.4 mmol/l MgSO4, 1 mmol/l 
CaCl2 and 10 mmol/l Hepes, pH 7.4) supplemented with 0.5 % 
fatty-acid-free BSA, 2 mmol/l pyruvate and 5.5 mmol/l glucose. 
With the exception of the hypoxic buffer treatment, cells were 
continuously gassed with 95 % O2/5 % CO2 to pH 7.4 throughout 
the treatments. For insulin stimulation, cells were incubated with 
30 nmol/l insulin for 30 min at 37 ◦C. Where indicated in the 
Figure legends, cardiomyocytes were pre-treated with 100 nmol/l 
wortmannin or the equivalent amount of DMSO (�0.1 %). Stim­
ulation by hypoxia was induced by incubation in KRH buffer with 
0.5 % fatty-acid-free BSA that had been deoxygenated for 60 min 
and pre-gassed with nitrogen for a further 30 min. The nitrogen 
atmosphere was maintained throughout subsequent incubations. 
Chemically induced hypoxia was achieved by treating the cells 
with 5 μmol/l oligomycin for 60 min. For electrical stimulation 
of contraction, 1 ml aliquots of cell suspensions at 37 ◦C, 10 % 
cytocrit, were placed in 19 mm diameter polystyrene dishes. 
Electrodes (attached to a dish lid) were dipped into the cell 
suspension. Cells were stimulated at exercise levels of contraction 
for 5 min at 100 V, with pulse duration of 1 ms and frequency of 
10 Hz. Contraction was monitored under a microscope. For all of 
the conditions used in the present study, no more than a 10 –20 % 
decrease of the initial cell viability was observed. 
Indirect immunoﬂuorescence microscopy 
Stimulated cardiomyocytes were ﬁxed by incubation with 4 % 
(w/v) paraformaldehyde in KRH buffer for 30 min at room 
temperature (20–22 ◦C), and washed three times with PBS. 
The cells were then maintained in blocking buffer [1 % (w/v) 
BSA and 3 % (v/v) goat serum in PBS] for 40 min at room 
temperature. For localization of the plasma membrane, ﬁxed cells 
were ﬁrst incubated with biotinylated Lens culinaris agglutinin 
(LcH) (Sigma) for 30 min at room temperature, washed with 
PBS to remove unbound LcH, incubated with streptavidin Alexa 
Fluor® 633 conjugate (Molecular Probes) and then washed again 
with PBS. Cells were then treated with permeabilization buffer 
[0.1 % saponin, 1 % (w/v) BSA and 3 % (v/v) goat serum in 
PBS] for 45 min and incubated with 10 μg/ml of rabbit anti-
rat NHE1 antibody overnight at 4 ◦C. The following day, the 
cells were washed in permeabilization buffer, incubated with 
Alexa Fluor® 488 goat anti-rabbit IgG (4 μg/ml; Molecular 
Probes) for 2 h at room temperature and then washed again 
in permeabilization buffer. The co-localization of NHE1 with 
GLUT4was determined in cardiomyocytes that were incubated as 
above for localization of NHE1, but with the subsequent addition 
of 0.1 μg/ml mouse monoclonal anti-GLUT4 antibody (Clone 
1F8, Biogenesis) overnight at 4 ◦C and then Alexa Fluor® 568­
conjugated goat anti-mouse IgG (Molecular Probes) for 2 h at 
room temperature with a ﬁnal wash step in permeabilization 
buffer. Cellsweremounted on to a glass coverslipwithVectashield 
mounting medium (Vector Laboratories). 
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Confocal microscopy was performed on a Zeiss LSM 510 
META microscope with a 63 × 1.4 NA (numerical aperture) 
oil-immersion objective and with dual- or triple-laser excitation 
at 458–488, 543 and 633 nm. Images were processed using the 
Zeiss LSM Image analysis software and Adobe Photoshop. For 
quantiﬁcation of the changes in NHE1 distribution, the intensities 
of NHE1 and LcH ﬂuorescence were sampled along radial lines 
across the perinuclear area to the sarcolemma and intercalated 
disk surfaces. The proportion ofNHE1 signal that overlappedwith 
LcH signal at the cell surfaces was calculated as the percentage 
of the total NHE1 sampled along the radial line (Figure 2A). 
Cell-surface biotinylation 
Levels of NHE1 at the cell surface were assessed by a surface-
protein biotinylation method based on methods described 
previously [17,26]. Cells were treated under conditions indicated 
in the Figure legends and then cooled to 15 ◦C for  5  min.  
A cell-impermeant biotin analogue, EZ-Link-Sulfo-NHS-SS-
Biotin (Pierce), was added to the cells at a ﬁnal concentration 
of 180 μmol/l for 15 min. The reaction was terminated by 
washing the cells with ice-cold KRH and transferring to ice-
cold TES buffer [25 mmol/l Tris/HCl (pH 7.4), 1 mmol/l EDTA 
and 0.25 mol/l sucrose] containing protease inhibitors [antipain, 
aprotinin, pepstatin A and leupeptin (each at 1 μg/ml) and 100 
μmol/l 4-(2-aminoethyl)benzenesulfonyl ﬂuoride)]. Membrane 
pellets were prepared by a modiﬁcation of a method that has 
been described previously [27]. Brieﬂy, cells were homogenized 
in ice-cold TES buffer with 30 strokes of a Potter–Elvenjem 
homogenizer. Homogenates were then subjected to centrifugation 
(48000 g for 30 min at 4 ◦C). 
The cell pellets were resuspended in TBS [Tris-buffered 
saline; 25 mmol/l Tris/HCl (pH 7.4) and 140 mmol/l NaCl] 
and solubilized in lysis buffer [1 % (w/v) Triton X-100, 1 % 
(w/v) sodium deoxycholate, 0.2 % SDS, 25 mmol/l Tris/HCl 
(pH 7.4) and 140 mmol/l NaCl] containing protease inhibitors 
for 2 h at 4 ◦C. The solubilized membranes were adjusted for 
equal protein content and incubated overnight with 50 μl of  
a 50  % slurry of immobilized streptavidin on agarose beads 
(Pierce). After the pull-down, beads were washed twice with 
lysis buffer, twice with TBS and once with TE buffer [10 
mmol/l Tris/HCl (pH 7.4) and 5 mmol/l EDTA). Proteins were 
eluted in SDS/PAGE sample buffer containing 100 mmol/l 
dithiothreitol, separated by SDS/PAGE and electrotransferred 
on to nitrocellulose membranes. Western blot analysis of 
samples precipitated with streptavidin–agarose was performed 
using a monoclonal anti-NHE1 antibody (Chemicon, MAB3140 
clone 4E9) and a horseradish-peroxidase-conjugated secondary 
antibody (Pierce). Signals were detected by ECL (enhanced 
chemiluminescence) andwere quantiﬁed usingEpi-Chemi IIDark 
Room equipment and LabWorks analysis software (UVP). 
A control biotinylation experiment was performed to conﬁrm 
the speciﬁcity of the biotinylation of NHE1 by processing the 
cardiomyocytes in the same way as described above with 
the following modiﬁcations. At the end of the treatments, 
the cardiomyocytes were labelled with EZ-Link-Sulfo-NHS­
LC-Biotin (Pierce) instead of EZ-Link-Sulfo-NHS-SS-Biotin 
to avoid cleavage of the biotin moiety during the processing 
of the samples. The cardiomyocytes were then processed as 
described above, but the detergent-solubilized membrane samples 
were immunoprecipitated with 8 μg of rabbit anti-rat NHE1 
antibody overnight. The following day, 20 μl of a 50  % slurry 
of immobilized Protein A (Pierce) was added to the samples 
and incubated for a further 3 h at 4 ◦C. The immunoprecipitated 
NHE1 was then resolved by SDS/PAGE and transferred on to 
nitrocellulose for blotting using Extravidin-peroxidase conjugate 
(Sigma) to detect the biotinylated proteins. 
RESULTS 
Subcellular localization of NHE1 in cardiomyocytes 
In order to investigate the subcellular localization of NHE1 in 
cardiomyocytes, a rat NHE1-speciﬁc antibody was developed. 
This antibody was then used to study the subcellular localization 
of NHE1 in rat cardiomyocytes by immunoﬂuorescence and 
confocal microscopy. In agreement with a previous study 
[28], immunoﬂuorescent detection of endogenous NHE1 in 
non-stimulated cardiomyocyte membranes revealed that NHE1 
preferentially localized at the intercalated disks and the 
sarcolemma. NHE1 was also localized in t-tubule regions 
identiﬁed as distinctive lines running transversely across the cell 
and at 90◦ to the longitudinal region of sarcolemma (Figure 1, left­
hand panels). At the sarcolemma and t-tubules of unstimulated 
basal cardiomyocytes, NHE1 was localized in punctate spots 
of varying intensity. NHE1 was also seen at deeper perinuclear 
locations. 
In insulin-stimulated cardiomyocytes, NHE1 distribution at 
the sarcolemma was more uniform and homogenous compared 
with the punctate sarcolemma distribution observed in basal 
cells (Figure 1, left-hand panels). One of the problems 
associated with use of confocal microscopy to demonstrate 
protein translocation to the limiting cell membranes is that, 
on fusion with the limiting membrane, any signal becomes 
more delocalized and indistinct. The signal from proteins 
inserted into the limiting membrane is difﬁcult to detect 
unless the extent of co-localization with a plasma membrane 
marker protein is determined. This phenomenon is documented 
in numerous studies examining the translocation of GLUT4 in 
cardiomyocytes and skeletal muscle cells and cell lines. We have 
previously quantiﬁed the translocation of endogenous GLUT4 
in cardiomyocytes using immunocytochemical techniques by 
comparing the GLUT4 and syntaxin 4 co-localization at the 
sarcolemma [17]. To quantitatively evaluate the extent of NHE1 
translocation to the sarcolemma we labelled the cell surface with 
a biotinylated Lens culinaris agglutinin (LcH) in conjunction 
with an Alexa Fluor® 633–streptavidin conjugate. LcH labels 
the whole of the sarcolemma, but not the t-tubules (Figure 1, 
middle panels). We determined the level of NHE1 signal that 
overlapped with that of LcH at the intercalated discs and the 
longitudinal edge regions of the sarcolemma and expressed this 
level as a percentage of the total NHE1 sampled (Figures 2A and 
2B). We did not observe any difference in the pattern of NHE1 
redistribution along the longitudinal edge of the sarcolemmawhen 
compared with the intercalated discs, so the data from these two 
regions of the sarcolemma were combined. The NHE1 levels at 
the sarcolemma were found to increase in response to insulin, to 
oxidative metabolism stress induced by hypoxia or oligomycin 
treatment, and after electrical stimulation to mimic contraction. 
For all of the stimuli, an increase of ∼2-fold in the amount of 
NHE1 at the sarcolemma was observed (Figure 2B). 
Comparison of NHE1 and GLUT4 translocation 
NHE1 has been primarily considered to be a plasma membrane 
resident protein and has not previously been considered to be 
regulated by translocation in cardiomyocytes. We therefore 
compared the trafﬁc of NHE1 with that of the well studied 
and established process of translocation of the glucose 
transporter GLUT4 using comparable immunoﬂuorescent 
microscopy techniques. NHE1 and GLUT4 have remarkably 
c © 2010 Biochemical Society © The Authors Journal compilation c
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Figure 1 Immunocytochemical analysis of NHE1 subcellular distribution in 
insulin-, hypoxia- and contraction-stimulated cardiomyocytes 
Isolated cardiomyocytes were maintained in a basal unstimulated state or incubated in one of 
the following conditions: with 30 nmol/l insulin for 30 min, in a hypoxic buffer for 15 min, with 
5 μmol/l oligomycin for 60 min, or electrically stimulated to contract for 5 min. After the 
treatments, cells were washed brieﬂy and ﬁxed with 4 % (w/v) paraformaldehyde. After 
permeabilization with 0.1 % saponin, cells were incubated with rabbit anti-rat NHE1 antibody 
and Alexa Fluor® 488-conjugated anti-rabbit IgG (green) (left-hand panels) and visualized 
by confocal microscopy. All cells were viewed in approximately the same focal plane. For 
quantiﬁcation of the changes in the NHE1 levels at the sarcolemma, non-permeabilized cells were 
labelled with LcH and streptavidin–Alexa Fluor® 633 conjugate (red) prior to proceeding to the 
immunolabelling of NHE1 (middle panels). Merged images are shown in the right-hand panels. 
Control cells were incubated with rabbit anti-rat NHE1 antibody that had been pre-incubated 
with the puriﬁed NHE1 fragment that was used as the antigen. Immunoﬂuorescent images 
shown are representative from 8–31 cells examined per condition from three to ﬁve independent 
experiments. Scale bars = 20 μm. 
similar patterns of distribution throughout the cardiomyocytes 
(Figure 3). In the basal state, both proteins are present at 
high levels deep within the cell in the perinuclear region and 
within punctate structures throughout the cell interior. On 
Figure 2 Quantiﬁcation of the extent of redistribution of NHE1 along radial 
lines from the perinuclear area to the sarcolemmal surface (SM) 
(A) Representative intensity distribution proﬁles of NHE1 along radial lines across the perinuclear 
area to the sarcolemma. (B) The proportion of NHE1 that co-localized with LcH (red) at the 
sarcolemmal surface was calculated as a percentage of the total NHE1 sampled. Results are 
means from 8–31 cells selected at random per condition per experiment and from three to ﬁve 
independent experiments. ***P < 0.05, compared with the basal value. 
insulin stimulation, translocation of both proteins occurs. Close 
examination of images suggests that there is less punctate 
NHE1 and GLUT4 in the region of the sarcolemma following 
stimulation with insulin, but this change in distribution is not 
immediately obvious for either transporter protein unless plasma 
membrane markers are used. The translocation of GLUT4 in 
cardiomyocytes is much more visually apparent using a HA 
(haemagglutinin)–GLUT4–GFP (green ﬂuorescent protein) 
construct and detection with a ﬂuorescent anti-HA antibody that 
recognizes only cell-surface-exposed proteins [29]. 
Both NHE1 (Figure 1) and GLUT4 [30] translocate to the 
limiting membranes of cardiomyocytes in response to insulin 
action and stimuli (including hypoxia and contraction) that 
impinge upon the energy-status signalling pathway. Both 
transporters show a similar pattern of subcellular distribution 
© The Authors Journal compilation c© 2010 Biochemical Society c
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Figure 3 Comparison of NHE1 and GLUT4 subcellular distribution in cardiomyocytes 
Isolated cardiomyocytes were maintained in the basal unstimulated state or were incubated with 30 nmol/l insulin for 30 min. Cells were then washed, ﬁxed and permeabilized as described in the 
Experimental section. The cardiomyocytes were incubated with rabbit anti-rat NHE1 antibody and Alexa Fluor® 488-conjugated anti-rabbit IgG (green) and mouse anti-GLUT4 antibody and Alexa 
Fluor® 568-conjugated anti-mouse IgG (red). Immunolabelled cells were visualized by confocal microscopy. All cells were viewed in approximately the same focal plane. The panels on the right-hand 
side represent zoomed images of square delimited areas indicated in the merged images. Scale bars = 10 μm. Immunoﬂuorescent images shown are representative from ﬁve to ten cells examined 
per condition from three to ﬁve independent experiments. 
among intracellular compartments both in the perinuclear and 
t-tubule regions. However, there is surprisingly little overlap 
between the localization of NHE1 and GLUT4 (Figure 3; merged 
image, third panel, and zoomed image, fourth panel) particularly 
in the basal state. There is some co-localization or overlap of 
signals in the perinuclear region, but the distribution of punctate 
structures throughout the rest of the cell is distinct and non-
overlapping. It appears that red (GLUT4) and green (NHE1) 
localization signals alternate along the radial axis that leads to 
the sarcolemma (Figure 3, zoomed images). 
Modulation of NHE1 levels at the cell surface of rat cardiomyocytes 
in response to insulin 
We found that subcellular fractionation of membranes 
from cardiomyocytes could not resolve translocation of 
either NHE1 or GLUT4 (Supplementary Figure S1 at 
http://www.BiochemJ.org/bj/432/bj4320515add.htm). In order 
to conﬁrm the immunocytochemical evidence for regulated 
translocation of NHE1, we therefore applied a cell-surface 
biotinylation technique and used an impermeant cleavable biotin 
succinimide reagent Sulfo-NHS-SS-Biotin to covalently tag the 
cell-surface protein. Following the pre-incubation treatments 
described in the Figure legends, cardiomyocytes were maintained 
with these treatments and in the presence of the biotinylating 
reagent. After washing away the unbound biotinylation reagent, 
membranes were prepared and solubilized and this material was 
subjected to streptavidin precipitation and SDS/PAGE resolution 
of the precipitated proteins. Western blot analysis with anti­
NHE1 antibody revealed that insulin treatment induced an 
increase of the amount of biotinylated NHE1 at the cell surface, 
thus conﬁrming the results observed by confocal microscopy 
(Figure 4A). The quantiﬁcation of the blotting data indicated 
that insulin induced a 2.8-fold increase in the level of NHE1 
present in the cell surface of cardiomyocytes. This increase was 
complete within 30 min and occurred without any change in 
the total level of NHE1 present in the cells as detected, using the 
same NHE1 antibody, when blotting the detergent-solubilized 
cell membrane control (Figure 4A, lower blot). Insulin is known 
to activate multiple signalling pathways in cardiomyocytes. 
However, one of the major limbs in insulin signalling is through 
the activation of PI3K. To investigate whether PI3K is involved 
in the insulin-stimulated increase in cell-surface levels of NHE1, 
the biotinylation experiment was performed in the presence of 
wortmannin, a PI3K inhibitor. Wortmannin pre-treatment blocked 
the insulin effect, but did not affect the level of biotinylation of 
NHE1 in the basal cells (Figures 4A and 4B). 
An alternative method for processing and analysing the extent 
of cell-surface biotinylation of NHE1 was also examined. After 
labelling with the impermeant biotinylating reagent, solubilized 
membranes were subjected to immunoprecipitation with rabbit 
anti-rat NHE1 antibody. Control samples were subjected to 
the same procedure but using a non-speciﬁc IgG pull-down. 
After resolution of the NHE1 by electrophoresis, the levels of 
biotinylated NHE1 were detected using Extravidin-peroxidase. 
These results (Figure 4C) conﬁrmed the insulin-stimulated 
increase of NHE1 at the cell surface and also the speciﬁcity of the 
biotinylation technique in detecting variations in NHE1 levels. 
Modulation of NHE1 levels at the cell surface of rat cardiomyocytes 
in response to oxidative metabolism stress and contraction 
Disrupted oxidative metabolism and stimulated contraction alter 
the energy status of the cells. Readjustments of cell glucose 
metabolism, the AMP/ATP ratio and pHi are necessary after such 
treatments. In the case of GLUT4 translocation, the signalling 
that follows these stimuli is independent of PI3K and is instead 
correlatively associated with increases in AMPK [30]. Treatment 
of the cardiomyocytes under hypoxic conditions led to a 
3-fold increase in cell-surface biotinylation of NHE1 (Figure 5A). 
Quantiﬁcation of these data (Figure 5B) revealed that this change 
was not additive to the insulin effect. When the cells were pre­
treated with insulin prior to hypoxia stimulation, no further 
increase in the amount of biotinylated NHE1 was observed. 
Similar results were obtained following disruption of the energy 
status of the cardiomyocytes by treatment with the mitochondrial 
c © 2010 Biochemical Society © The Authors Journal compilation c
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Figure 4 Treatment with insulin increases the abundance of NHE1 at the 
cell surface through a PI3K-dependent mechanism 
(A) Isolated cardiomyocytes were incubated for 30 min with or without 30 nmol/l insulin. 
Where indicated, cells were pre-treated for 15 min with 100 nmol/l wortmannin before the 
addition of insulin. Cardiomyocytes were then cooled to 15 ◦C, labelled with 180 μmol/l 
Sulfo-NHS-SS-Biotin, washed and membranes prepared. Membranes were solubilized (20 μg 
of protein was taken for a loading control), biotinylated protein was precipitated with immobilized 
streptavidin, the precipitated proteins were separated by SDS/PAGE and NHE1 was detected 
by Western blot analysis. The blots are representative of ﬁve independent experiments. 
(B) Quantiﬁcation data from the Western blot results. The histogram represents the means 
+− S.E.M. from ﬁve independent experiments. *P < 0.05, compared with the basal value. (C) 
Isolated cardiomyocytes were treated as described in (A) above, but solubilized membrane 
proteins were immunoprecipitated either with rabbit anti-rat NHE1 antibody or non-specﬁc IgG 
and Protein A. The precipitated proteins were separated by SDS/PAGE and biotinylated proteins 
were detected by Western blot analysis using an Extravidin-peroxidase conjugate. The blot 
represents a typical result from three independent experiments. IP, immunoprecipitation. For (A) 
and (C), the molecular mass in kDa is indicated on the left-hand side. 
ATPase (F1) inhibitor oligomycin (Figures 5A and 5B). Electrical 
stimulation of contraction led to a large 4-fold increase in 
NHE1 levels at the cell surface. Wortmannin inhibition of 
PI3K activity did not affect the redistribution of NHE1 to the 
cell surface that occurred in response to hypoxia, oligomycin 
or electrical stimulation of contraction (Figures 5A and 5B), 
suggesting that these stimuli affect NHE1 by PI3K-independent 
processes. Treatment of cardiomyocytes with Compound C 
gave a partial inhibition of the contraction response consistent 
with an AMPK involvement (Supplementary Figure S2 at 
http://www.BiochemJ.org/bj/432/bj4320515add.htm). However, 
Compound C is now known to have quite poor speciﬁcity for 
selective inhibition of AMPK signalling [31]. 
DISCUSSION 
In the present study, we have shown for the ﬁrst time that NHE1 
levels at the sarcolemma of cardiomyocytes are acutelymodulated 
in response to stimulation by insulin or through changes in 
cell-energy status. Since regulation of NHE1 translocation in 
cardiomyocytes is somewhat unexpected, we conﬁrmed the 
occurrence of this process using the complementary techniques of 
immunoﬂuorescence microscopy and cell-surface biotinylation. 
The microscopy is most useful for determining the changes in 
localization of NHE1, but is limited by quite poor resolution 
of the NHE1 that has become incorporated into the limiting 
sarcolemma membrane, unless this distribution is compared with 
that of a limiting membrane marker such as LcH. The cell-surface 
biotinylation technique is more useful for quantiﬁcation of a range 
of responses to modulators and inhibitors. 
Other NHE isoforms have been shown to redistribute in 
response to signalling. The translocation of NHE3, the apical 
epithelial isoform of kidney and intestine, has been most studied. 
In the proximal tubule of kidneys, NHE3 redistributes from 
the apical plasma membrane to a sub-apical endomembrane 
location in response to hypertension or increased intervascular 
pressure [32,33]. Increased apical cell-surface expression of 
NHE3 in epithelial tissues occurs in response to angiotensin 
II, glucocorticoids and insulin, but this may be partly due to 
increased cellularNHE3 levels (reviewed in [34]). NHE5 is almost 
exclusively expressed in the brain and translocates between the 
cell surface and recycling endosomes. This process has been 
reported to be mediated by PI3K and to be dependent on an intact 
actin cytoskeleton [35]. Recently, the small GTPase Arf6 together 
with SCAMP2 (secretory carrier-associated membrane protein 2) 
was reported to positively regulate the NHE5 recycling process in 
neurons [36]. The recruitment of NHE1 may be cell-type-speciﬁc 
and dependent on cell-speciﬁc demands for regulation of pHi. 
In platelets, there is no detectable translocation of NHE1 and 
all the available NHE1 is present at the cell membrane in the 
unstimulated basal state [37]. 
Insulin is known to induce cell alkalinization in culturedmuscle 
and adipose cell lines [38,39], adipocytes [18], cardiomyocytes 
[17] and erythrocytes [40]. The insulin-induced pH changes have 
been linked to activation of the PI3K signalling pathway. We have 
previously found that the insulin action on cell alkalinization 
in adipocytes [18] and cardiomyocytes [17] is associated with 
increased PI3K-dependent GLUT4 translocation. In the present 
study, we have demonstrated that the insulin effect on NHE1 
translocation is also mediated through the PI3K pathway, as 
wortmannin completely abolished the observed increase in NHE1 
levels at the cell surface. 
Alterations in the oxidative metabolism of cardiomyocytes 
induced by hypoxia or by treatment with the mitochondrial 
inhibitor oligomycin also led to elevated levels of NHE1 at the 
cell surface. However, the mechanism involved in this stimulation 
is different from the insulin activation process, as wortmannin 
did not modify the levels of NHE1 at the cell surface of 
cardiomyocytes incubated in hypoxic conditions or treated with 
oligomycin. Changes in the AMP/ATP ratio occur in response 
to these treatments and are thought, at least in the case of 
GLUT4 trafﬁc, to be associated with altered net translocation 
and retention at the cell surface. Contraction-induced NHE1 
redistribution was also observed to be independent of PI3K 
signalling and insensitive to wortmannin inhibition. Contraction-
induced signalling in cardiomyocytes and skeletal muscle only 
partly correlates with activation of AMPK [30,41], and the details 
of the signalling mechanism by which increased contraction 
signals to GLUT4 trafﬁc are currently unclear. No additivity in 
the combined responses of NHE1 translocation to insulin and 
changes in cell-energy status were observed in cardiomyocytes in 
the present study. This contrasts with effects of these stimuli on 
GLUT4 translocation. It is possible that only a single limited 
population of NHE1 exchangers is available for translocation 
© The Authors Journal compilation c© 2010 Biochemical Society c
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Figure 5 Effects of hypoxia, oligomycin treatment and contraction on the abundance of NHE1 levels at the cell surface 
(A) Isolated cardiomyocytes were incubated in hypoxic buffer for 15 min, or treated with 5 μmol/l oligomycin for 60 min or were electrically stimulated to contract for 5 min. When indicated, cells 
were pre-incubated with 100 nmol/l wortmannin for 15 min. When the combined effect of insulin stimulation and hypoxia was studied, cardiomyocytes were ﬁrst incubated with 30 nmol/l insulin 
for 30 min and insulin was then maintained throughout the hypoxic treatment. When the combined effect of insulin and oligomycin treatment was examined, after 30 min of oligomycin treatment 
30 nmol/l insulin was added for the remaining 30 min of the oligomycin treatment. In each experiment, control cells were left untreated or incubated with 30 nmol/l insulin for 30 min. After the 
treatments, cardiomyocytes were cooled to 15 ◦C, labelled without (no biotin control, NBC) or with 180 μmol/l Sulfo-NHS-SS-Biotin. Membrane samples were solubilized (20 μg was taken for 
loading control, bottom panel), biotinylated protein was precipitated with immobilized streptavidin, the precipitated proteins were separated by SDS/PAGE and NHE1 was detected by Western blot 
analysis (top panel). The blots are representative of three to ﬁve independent experiments. (B) Quantiﬁcation data from Western blot results. The histogram represents the mean + S.E.M from three 
to ﬁve independent experiments. *P < 0.05, compared with the basal volume. 
and that all available NHE1 in this compartment is released in 
response to activation of either the PI3K or the AMPK signalling 
pathways. 
The regulated changes in NHE1 translocation may reﬂect the 
need for alkalinization of the cells when increased anaerobic 
glucose metabolism and an associated cell acidosis occurs [1]. 
The processes by which increased translocation of NHE1 occurs 
may use the same signalling machinery that is present in 
cardiomyocytes for generating increased GLUT4 translocation. 
Such a linkage would ensure that the increased glucose 
metabolism is associated with restoration of the cell AMP/ATP 
ratio and at the same time restoration of normal cellular pHi. 
Although the GLUT4 and NHE1 translocations appear to be 
triggered by common signalling steps, there must be some 
divergence in the respective links between signalling and trafﬁc as 
intracellular NHE1 and GLUT4 vesicle locations are distinct over 
large parts of the cell interior. However, there is some overlap 
between intracellular GLUT4 and NHE1 in the perinuclear 
regions of the cardiomyocytes, and this may be a site at which 
signals to the NHE1 and GLUT4 translocation systems converge. 
The role of NHE1 translocation and the relative importance of 
altered translocation compared with changes in intrinsic catalytic 
activity will need further investigation. Phosphorylation of NHE1 
downstream of Akt has been reported to lead to both an increase 
[16] in catalytic activity and a decrease [25]. Phosphorylation 
of NHE1 downstream of protein kinase A and protein kinase G 
leads to decreased catalytic activity, whereas activation of ERK 
downstream of protein kinase C and reactive oxygen species 
leads to stimulation of catalytic activity [1,42]. Increases in 
cellular calcium also lead to activation of NHE1 intrinsic catalytic 
activity via calmodulin- and CaMKII-dependent mechanisms 
[1,43]. Modulation of activity also occurs through alteration of 
the extent of interaction with the actin cytoskeleton [13,14]. With 
such ﬁne control of catalytic activity, the translocationmay appear 
to be redundant, superﬂuous and unnecessary. However, there is 
a very clear need for multiple mechanisms for control of pHi 
and NHE1 activity in cardiomyocytes [1]. There are requirements 
for very localized changes in pHi [44]. It would be of interest to 
determine the extent to which translocation of NHE1 is associated 
with altered phosphorylation. Mathematical models have been 
used to analyse experimental kinetic data on NHE1 activity in 
cardiomyocytes and have suggested that catalytic activity alone 
may not fully account for the observed changes [45,46]. It would 
therefore be useful to incorporate regulated NHE1 translocation 
into models of control of total cellular and spatially localized 
NHE1 activity. 
In addition, phosphorylation-dependent changes in catalytic 
activity may exert different temporal control of NHE1 activity 
in comparison with translocation. Prolonged treatment with 
interferon-γ , in addition to the already reported inhibition of 
NHE1 activity, increased NHE1 localization to the cell surface 
of human intestinal epithelial cells without affecting the total 
amount of NHE1 in the cell [47,48]. The observed increase in the 
cell-surface localization of NHE1 was obtained after a prolonged 
24 h treatment with interferon-γ . By contrast, in cardiomyocytes 
we observed translocation changes in NHE1 within 15–30 min 
of treatment, but this change could be associated with even more 
immediate changes in catalytic activity. The combination of a 
range of control mechanisms would allow temporal versatility in 
response to challenges to cell pH homoeostasis. 
c © 2010 Biochemical Society © The Authors Journal compilation c
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Perturbed integration of control of insulin action on GLUT4 
translocation, glucose transport, glucose metabolism and NHE1 
activity may be important in disease states including Type 2 
diabetes. In the Goto–Kakizaki rat model for Type 2 diabetes, 
cellular NHE1 levels and activity are activated [49]. However, 
decreases in NHE1 activity are associated with decreased 
pancreatic insulin secretion occurring in the streptozotocin model 
of Type 1 diabetes [50]. Examination of the role of the newly 
discovered process of insulin and energy-status control of NHE1 
translocation in these disease processes seems warranted. Such 
studies may help to further elucidate how GLUT4 translocation, 
glucose metabolism, pHi, NHE1 activity and NHE1 translocation 
are linked, and may provide insights into how metabolic disease, 
including insulin resistance, affects cardiac function. 
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Translocation of the Na+/H+ exchanger 1 (NHE1) in cardiomyocyte 
responses to insulin and energy-status signalling 
Scott P. LAWRENCE1, Geoffrey D. HOLMAN2 and Franc¸oise KOUMANOV 
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Figure S1 Distribution of NHE1 and GLUT4 in rat cardiomyocyte membrane 
fractions 
Cardiomyocytes were left untreated (B) or incubated with 30 nmol/l insulin for 30 min (I). 
Trafﬁcking was arrested by the addition of 5 mmol/l sodium azide and cooling to 15◦C. 
Cells were homogenized in ice-cold TES buffer [25 mmol/l Tris/HCl (pH 7.4), 1 mmol/l EDTA 
and 0.25 mol/l sucrose] containing protease inhibitors with 30 strokes of a Potter–Elvenjem 
homogenizer. The cell homogenate was subjected to differential centrifugation by an adaptation 
from a previously described method [1]. Cell homogenate was spun at 100 g for 10 min to 
pellet unbroken cells, t-tubules and nuclei. The cleared supernatant was spun at 20 000 g for 
30 min to obtain a crude plasma membrane fraction. The resulting supernatant was spun at 
48 000 g for 30 min and yielded a pellet of high-density microsomes. The cleared supernatant 
was spun at 250 000 g for 60 min and the resulting pellet contained low-density microsomes. 
Using this method, the plasma membrane marker Na+/K+ ATPase partitioned in the plasma 
membrane fraction by 70 % (results not shown). A 20 μg aliquot of each fraction was resolved 
by SDS/PAGE, and NHE1 (top panel) or GLUT4 (bottom panel) was detected by Western blot 
analysis. The blots are representative of two similar experiments. 
1 Present address: Institute for Structural and Molecular Biology, Division of Biosciences, University College London, Gower Street, London WC1E 6BT, 
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Figure S2 Effect of Compound C on cell-surface NHE1 levels 
(A) Isolated cardiomyocytes were incubated for 15 min at 37 ◦C with 1 μmol/l Compound C (Calbiochem) in DMSO (�0.1 %) or with DMSO alone. Cardiomyocytes were electrically stimulated to 
contract for 5 min. In each experiment, control cells were left untreated or incubated with 30 nmol/l insulin for 30 min. After the treatments, cardiomyocytes were cooled to 15 ◦C and labelled with 
180 μmol/l Sulfo-NHS-SS-Biotin. Membrane samples were solubilized (20 μg was taken for a loading control; bottom panel), biotinylated protein was precipitated with immobilized streptavidin, 
and then the precipitated proteins were separated by SDS/PAGE. NHE1 was detected by Western blot analysis (top panel). The blots are representative of three to ﬁve independent experiments. 
(B) Quantiﬁcation of Western blot analysis. Results are the means+S.E.M. from three to ﬁve independent experiments. *P < 0.05 compared with contraction. 
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